Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting the endocannabinoid system in the treatment of fragile X syndrome

31 Mar 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cannabis and Cannabinoid Research
Share to Genetics and Neurodevelopmental Disorders
Share to Pancreatic function and diabetes

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23542787
DOI: 10.1038/nm.3127

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting the endocannabinoid system in the treatment of fragile X syndromePMID 23542787Read ↗

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatmentSemantic proximity Read ↗

Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidenceSemantic proximity Read ↗

Pharmacological management of fragile X syndrome: a systematic review and narrative summary of the current evidence.Semantic proximity Read ↗

The endocannabinoid system in cancer—Potential therapeutic target?Semantic proximity Read ↗

The endocannabinoid signaling system in cancerSemantic proximity Read ↗

Fragile X syndrome: A review of clinical managementSemantic proximity Read ↗

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunitiesSemantic proximity Read ↗

A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)Semantic proximity Read ↗

Fragile X syndrome.Semantic proximity Read ↗

Metabolic Messengers: endocannabinoidsSemantic proximity Read ↗

Fragile X syndrome: a psychiatric perspective.Semantic proximity Read ↗

Regulation of male fertility by the endocannabinoid systemSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.